InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $8.62M USD in the quarter ending September 30, 2024, with 111.22% growth. This brings the company's revenue in the last twelve months to $28.93M, up 192.24% year-over-year. In the year 2023, InnoCan Pharma had annual revenue of $13.66M with 433.69% growth.

• Revenue (ttm): $28.93M
• Revenue Growth: +192.24%
• P/S Ratio: 1.41
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 58.02M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.66M	11.10M	433.69%
Dec 31, 2022	2.56M	2.36M	1,205.61%
Dec 31, 2021	196.00K	188.00K	2,350.00%
Dec 31, 2020	8.00K	-	-
Dec 31, 2019	-	-	-